|
|
Article: Genetic Engineering News' Poll Indicates Need for More Vaccine Products.
- Article from:
- Business Wire
- Article date:
- November 29, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LARCHMONT, N.Y. -- The recent Fluvirin contamination problem that led to a significant shortage of the vaccine in the U.S. may lead to more research on vaccines, according to a Genetic Engineering News (GEN) website poll (www.genengnews.com). Three-hundred-and-twelve individuals answered the poll, the results of which appear on page 1 of the November 15 issue of GEN.
The readers responded to the question "Will the Fluvirin debacle stimulate more R&D on all types of vaccines by biotech and pharmaceutical companies?" The results: 218 (70%) said "yes" and 94 (30%) replied "no."
"Because many biotech and pharmaceutical companies not only do not see much of ...